Implementation of a diagnostic stewardship intervention for suspected pneumonia at a Michigan hospital was associated with a reduction in positive respiratory cultures and broad-spectrum antibiotic use, researchers reported last week in Clinical Microbiology and Infection.
Using a quasi-experimental clinical trial format, researchers at the University of Michigan Medical School examined the impact of a bundled, ventilator-associated pneumonia–specific diagnostic stewardship intervention (VAP-DSI) implemented at Michigan Medicine University Hospital. The goal of the VAP-DSI was to reduce the rate of diagnostic error in VAP, which is responsible for most antibiotic use in the intensive care unit but is frequently misdiagnosed because of diagnostic errors.
"Because respiratory cultures are fundamental to the management of VAP—a serious infection affecting critically ill patients with limited margin for diagnostic error—efforts to regulate their use have proven historically challenging," the study authors wrote. "The current VAP diagnostic paradigm, however, is fraught with overdiagnosis and consequent antimicrobial overuse."
Among the bundled interventions in the VAP-DSI was gatekeeping access to respiratory culture ordering.
Fewer antibiotic days of therapy
Comparing the 5 years before the intervention (2017 to 2022) with 1 year post-intervention (2022 to 2023), researchers examined rates of adverse safety outcomes, positive respiratory cultures, and antimicrobial use in mechanically ventilated patients (MVPs). A total of 687 MVPs were admitted in the post-intervention period, compared with 4,205 in the pre-intervention period.
VAP-DSI was not associated with an observed increase in adverse safety outcomes, such as ventilator-associated events or deaths per 1,000 MVP days, but it was associated with a 20% relative reduction in positive respiratory cultures per MVP days (pre-intervention rate 127, post-intervention rate 102). In addition, antibiotic days of therapy fell from 1,199 per 1,000 MVP days to 1,149.
Although they couldn't determine the relative impact of each component of the intervention, the authors suggest the reduction in the rate of positive respiratory cultures was primarily driven by reduced test ordering.
"This study provides proof-of-concept that carefully constructed VAP-DSIs represent safe and feasible avenues for ASPs," they wrote.